Thu, May 1, 8:34 PM (17 days ago)
**Teladoc Health, Inc. (TDOC) Q1 2025 Financial Summary** **Financial Health & Performance:** - **Revenue:** $629.4 million, a 3% decrease YoY. - **Profit Margins:** Net loss of $93.0 million, a 14% increase in net loss YoY. - **Cash Flow:** Net cash provided by operating activities was $15.9 million, an improvement from $8.9 million in Q1 2024. - **Earnings Changes:** Adjusted EBITDA decreased by 8% to $58.1 million. **Segment Performance:** - **Integrated Care:** Revenue increased by 3% to $389.5 million. Adjusted EBITDA increased by 6% to $50.4 million. - **BetterHelp:** Revenue decreased by 11% to $239.9 million. Adjusted EBITDA decreased by 50% to $7.7 million. **Key Metrics:** - **U.S. Integrated Care Members:** Increased by 10.7 million, or 12%, to 102.5 million. - **Chronic Care Program Enrollment:** Increased by 3% to 1.151 million. - **BetterHelp Paying Users:** Decreased by 4% to 0.397 million. **Trends & Uncertainties:** - **Seasonality:** Historically, Q1 experiences weak operating income due to higher marketing spend and new customer acquisition. - **Legal Proceedings:** Ongoing litigation may impact financials, but management believes substantial defenses exist. - **Future Operations:** Plans to continue innovation, expand services, and potentially seek additional financing if needed. **Impact on Future Operations:** - **Acquisitions:** Completed acquisition of Catapult Health and UpLift Health Technologies, which may drive future growth. - **Cash Position:** $1.193 billion in cash and cash equivalents, expected to meet working capital and capital expenditure needs for at least the next 12 months. - **Debt Obligations:** $550.7 million of convertible senior notes due within the next quarter.